Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699357 | Clinical Oncology | 2010 | 5 Pages |
Abstract
Patients with good prognosis differentiated thyroid cancer are at risk from over-treatment with radioiodine thyroid remnant ablation. Some with unfavourable localised disease might benefit from an elective second dose.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G.J.G. Rees,